C-083

Carisoprodol-D₇ solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

• Formule empirique (notation de Hill): C₁₂H₁₇N₂O₄D₇
• Numéro CAS: 1218911-16-0
• Poids moléculaire : 267.37
• Numéro CE : 200-659-6
• Code UNSPSC : 41116107
• Nomenclature NACRES : NA.24

Propriétés

• Qualité: certified reference material
• Forme: liquid
• Caractéristiques: SNAP-N-SPIKE^®, SNAP-N-SHOOT^®
• Conditionnement: ampule of 1 mL
• Fabricant/nom de marque: Cerilliant^®
• Concentration: 100 μg/mL in methanol
• Technique(s): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Application(s): clinical testing
• Format: single component solution
• Température de stockage: −20°C
• Chaîne SMILES: [2H]C([2H])([2H])C(CCC)(C([2H])([2H])OC(N)=O)C([2H])([2H])OC(=O)NC(C)C
• InChI: 1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16)/i4D3,7D2,8D2
• Clé InChI: OFZCIYFFPZCNJE-GDXCJPCVSA-N

Description

Description générale

An internal standard for Carisoprodol testing or isotope dilution methods by GC/MS or LC/MS for clinical toxicology, urine drug testing, pain prescription monitoring or forensic analysis. Carisoprodol is a skeletal muscle relaxant sold under the trade names Soma^® and Sanoma. The drug is abused recreationally, often for its heavy sedating, relaxant, and anxiolytic effects.

Application

• Quantitation of Carisoprodol and Meprobamate in Biological Samples: A method using liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed for the quantitation of carisoprodol and its metabolite meprobamate in urine and plasma, contributing significantly to pharmacokinetic studies and drug metabolism research. This method enhances the precision of bioanalysis in therapeutic monitoring and forensic investigations (Slawson and Johnson-Davis, 2016).


• Simultaneous Determination in Human Plasma: A study presented a liquid chromatography-tandem mass spectrometry method in polarity switch mode for simultaneous determination of carisoprodol and aspirin in human plasma. This method is crucial for pharmacokinetic studies and can be applied to clinical drug-drug interaction studies, offering insights into the bioavailability and metabolism of carisoprodol when co-administered with aspirin (Sreenivasulu et al., 2013).

Informations légales

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Soma is a registered trademark of Meda Pharmaceuticals Inc.

Informations sur la sécurité

• Pictogrammes: GHS02,GHS06,GHS08
• Mention d'avertissement: Danger
• Mentions de danger: H225,H301 + H311 + H331,H370
• Conseils de prudence: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• Classification des risques: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Organes cibles: Eyes
• Code de la classe de stockage: 3 - Flammable liquids
• Classe de danger pour l'eau (WGK): WGK 1
• Point d'éclair (°F): 49.5 °F - closed cup
• Point d'éclair (°C): 9.7 °C - closed cup